v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue
Cost of goods sold
Gross loss
Operating expenses:    
Research and development 124,864 307,730
General and administrative 1,576,191 1,665,822
Total operating expenses 1,701,055 1,973,552
Loss from operations (1,701,055) (1,973,552)
Other income (expense):    
Interest income 10,001 26,240
Change in fair value - warrant liability 1,080,600
Change in fair value - derivative liability (6,000) 1,531,000
Unrealized loss on marketable securities (8,846) (71,707)
Unrealized loss from remeasurement on digital assets (613,663)
Realized gain on marketable securities 37,977 211,062
Other income (expense), net (132,889) 41,368
Total other income (expense), net (713,420) 2,818,563
Net income (loss) prior to provision for income taxes (2,414,475) 845,011
Provision for income taxes
Net income (loss) (2,414,475) 845,011
Dividends earned on Series I and Series H-7 convertible preferred stock (166,671) (833,733)
Accretion of discounts to redemption value of Series I and Series H-7 convertible preferred stock (941,478) (1,686,854)
Net loss attributable to common stockholders $ (3,522,624) $ (1,675,576)
Net loss per share basic $ (2.42) $ (0.20)
Net loss per share diluted $ (2.42) $ (0.20)
Basic weighted average Common Stock outstanding 1,455,975 8,541,466
Diluted weighted average Common Stock outstanding 1,455,975 8,541,466